|Day Low/High||18.62 / 18.92|
|52 Wk Low/High||14.61 / 24.31|
U.S. stock futures are lower Thursday and European stocks fall as minutes from the Federal Reserve's April meeting appear to increase the chances of a rate hike in June.
Bayer falls in Germany on news of its takeover proposal to Monsanto, and package tour operator Thomas Cook sinks in London after curbing profit expectations.
Holding Monsanto stock may not pay off for investors. This chart shows why.
On a somber day, Salvatore Ferragamo cuts a dash as it parades higher profit despite declining sales.
He suggested investors get into Dow Chemical or DuPont instead.
The S&P 500 and Dow gave up earlier crude-inspired gains. Crude has traded near $47 a barrel earlier in the session, only to come back to around $46.
Monsanto, the world's largest seed producer, could be part of the latest industry megadeal.
Some are more liquid and open than others, says Matteo Andreetto, CEO of STOXX.
BP, Standard Chartered drive up the London bourse.
A weak cold season drives down consumer health revenue in the U.S.
The oil group joins several other heavy-hitters in posting above-forecast numbers.
European stocks rise Monday while Asian shares move higher.
Political pressure on Capitol Hill has been clobbering biotechs, but Europe-based "Big Pharma" juggernaut Bayer could surge in 2016 from a strong drug pipeline and ECB stimulus.
European stocks shrug off a slump in China even as crude oil falls again.
A German turbine-maker, a drug company and a semiconductor maker are among stocks recommended by Kevin Kelly of Recon Capital.
Shares of Siemens dropped over 14% in 2015, but a recent earnings report has given the German turbine-maker’s stock a jolt.
Investors often forget that the European Union is the world's largest economy. As the EU enjoys aggressive monetary stimulus in 2016, this undervalued drug giant will enjoy momentum.
Interest rates are set to rise in America and fall in Europe, setting the stage for growth for these stocks that the Oracle of Omaha is betting on for 2016.
Monsanto's third offer for the Swiss seeds company doesn't prove to be a charm.
Exporters led European stocks lower on Tuesday after China's surprise currency devaluation, as an unexpected fall in German investor confidence stoked concerns about the pace of recovery in Europe.
Why Germany? The overall attitude of the people is upbeat, new construction is ample enough to easily notice and the cost of gasoline is lower.
European stocks rose on Wednesday, driven by earnings from companies including Dutch phone giant Royal KPN and global luxury leader LVMH, as well as continued M&A deal momentum.
Zoetis in recent months has been the subject of takeover speculation, possibly for Valeant...
Among other things the Swiss firm's chairman said he wants a heftier breakup fee than what suitor Monsanto is offering.
Panasonic Healthcare, which is based in Tokyo and 80%-owned by KKR, would pay €1.02 billion ($1.15 billion) for the unit in a deal expected to close in the first quarter.
U.S. stock futures are rising as investors prep for data on mortgages and petroleum stockpiles, and as Target ups its dividend.
European stock indices edged higher on Wednesday, recovering from three-month lows, as reports stoked hopes that Greece may yet reach a debt deal. Bayer is selling its diabetes care business.
Add them together and you've got a perfect recipe for the markets.
Jim Cramer's charitable trust closed out its position in AbbVie on Tuesday, citing concerns for its 'expensive' acquisition plans for Pharmacylics.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.